跳至主要内容
临床试验/ACTRN12621001754831
ACTRN12621001754831已完成未知

A 3 month trial of the Oticon Tinnitus Sound Support feature in hearing aids for adults with hearing loss and tinnitus using the Tinnitus Functional Index as the primary outcome measure.

The University of Auckland0 个研究点目标入组 40 人开始时间: 2021年12月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

Results confirm previous findings that hearing aids assist in reducing the impact of tinnitus on daily life. The Oticon miniRITE combination hearing aids used in this study resulted in similar improvements for new and existing hearing aid users. This suggests tinnitus-reducing effects of these aids was greater than those already being used by participants.

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria were: Adults aged 18 years or above; Chronic tinnitus (at least 6 months since onset); New and experienced HA users with a symmetric slight (16 dB HL) to moderately severe (70 dB HL) binaural symmetric (PTA4 difference between ears of 15 dB or less) sensorineural or mixed flat or sloping hearing loss; HA fitting level for the 60- or 85-dB speaker and domes, or custom moulds including all types and configurations of hearing loss; Scores in the range of ‘Normal to Severe’ in each of the three categories on the Depression Anxiety and Stress Scale – 21 Items (DASS 21).

排除标准

  • Absence of tinnitus or hearing loss. A score of ‘Extremely Severe’ in any one of the three categories of the DASS 21; Objective, pulsatile tinnitus.

研究者

相似试验